document.writeln("
Rupee
recovers ground - bonds rise
Mumbai:
The rupee recovered some of its losses against the
greenback on Friday closing at 44.84/85, up from Thursday's
44.9450/9550.
Forwards
market: The 12-month premium closed at 0.47 per cent
(0.55) and the 6-month at 0.47 per cent (0.63).
G-Secs:
The 10.25-16 year-2021 paper closed at Rs125.45
(7.46 per cent YTM), higher than Thursday's Rs125.20 (7.49
per cent YTM). The 7.37-9 year-2014 paper ended
at Rs102.29 (7 per cent YTM). The 7.38-10 year-2015
benchmark paper closed at Rs101.80 (7.12 per cent YTM),
up from Thursday's Rs101.60 (7.15 per cent YTM).
Call
rates: The inter bank rates closed at 4 per cent (5-5.05).
Reverse
repo: In the three-day auction, the Reserve Bank of
India received and accepted 22 bids amounting to Rs9,255
crore.
CBLO
market: 335 trades, for Rs11,609.15 crore, were realised.
Back
to News Review index page
RBI:
T- Bill auctions
Mumbai: The Reserve
Bank of India proposes to raise Rs2,500 crore through
the auction of the 91-day and 182-day Treasury Bills,
under the Market Stabilisation Scheme. Of this Rs1,500
crore would be raised through the auction of 91-day T-bills,
while Rs1,000 crore would be raised through the auction
of 182-day T-bills.
According
to an RBI press release, the bank also proposes to raise
Rs1,000 crore through the regular auction, with Rs500
crore each to be raised in the auctions of the 91-day
T-Bills and 182-day-T bills respectively.
The
auctions will be conducted using `Multiple Price Auction'
method.
Tenders
should be submitted on October 19. Successful bidders
will have to make payment on October 21.
Back
to News Review index page
Citigroup
focusing on organic growth in India
Mumbai: Citigroup, one of the top banking groups
in the world, has said that it is focusing on organic
growth in India rather than embarking on the acquisition
route.
"Citigroup
is focused towards organic growth strategy. We would like
to take a patient view towards growth of business. We
have a lot of room to grow in India," said Citigroup
Global CEO Charles Prince, who is the first Citigroup
CEO to visit India after five years.
Prince
said Citigroup had the patience to go by the regulations
of the Reserve Bank of India. As of now, foreign banks
are not allowed to take over local banks. However, the
RBI has come out with a road map for listing and takeovers
by foreign banks by 2009.
Speaking
on India as an investment destination, Prince said ample
opportunities exist in India and Citigroup is positive
about Indian growth prospects and the group is retaining
all their earning from the country as investment. He also
stated there has been fresh capital infusion in the bank's
India operations time to time as per the requirements.
Prince
also said that currently the ratio of Citigroup's earning
from US vis-a-vis other global destinations was to the
tune of 60:40, but thte bank was aiming to reduce it to
50:50 in the next five years. Markets in Asia are likely
to grow rapidly when compared to Europe and Latin America,
he said.
Citigroup
has $10 billion in assets and 15,000 employees in India,
including outsourcing unit E-Serve and a finance company
Citicorp Finance Ltd through which it funds retail loans.
Back
to News Review index page
GDS
issue from India Cements raises US$100mn
Chennai:
India
Cements has raised US$100mn (about Rs450 crore) through
a Global Depositary Shares (GDS) issue. The issue is meant
primarily to extinguish some of the company's debt.
Following the inflow of GDS funds, India Cements' long-term
debt-equity ratio would stand at about 1.5:1 as compared
to a ratio of 5:1 at the beginning of the year. The GDS
would make up about 21.5 per cent of the company's equity.
The GDS was priced at about Rs95 a share, about 3 per
cent less than the closing price on the National Stock
Exchange (NSE) on October 13.
An India Cements press release said that the GDS pricing
"represents one of the tightest discounts witnessed
in recent times by an Indian GDS offering." The GDS
will be listed on the EuroMTF of the Luxembourg Stock
Exchange. The GDS issue included a greenshoe option of
US$15mn (about Rs67.5 crore), which has not yet been exercised.
This is the second largest equity transaction this year.
Earlier, the company reached a deal with a foreign institution
Asian Debt Management to raise Rs250 crore
through equity-related instruments. In addition to the
equity-related instruments, Asian Debt Management agreed
to invest an additional Rs405 crore through debt.
Asian Debt would hold about 17 per cent of the equity
in India Cements once it fully exercises the conversion
option in the equity-related instruments it currently
holds.
India Cements controls the largest cement capacity in
south India, i.e. about 9 million tonnes (including 1
million tonnes with Visaka Cement). The company registered
a net profit of Rs4.58 crore in 2004-05 after a period
of losses.
The India Cements press release said that ABN AMRO Rothschild
and Deutsche Bank acted as joint global coordinators and
joint book runners on this transaction.
Back
to News Review index page
Highest
ICRA rating of LAAA for Tata Power debentures
Mumbai: Tata
Power Company Ltd's Rs1,000-crore and Rs500-crore
non-convertible debenture programmes have received the
highest LAAA rating from Investment Information and Credit
Rating Agency (ICRA). The earlier rating was LAA+, informed
a press release issued by the company.
The
LAAA rating is the highest credit quality rating assigned
by ICRA, and signifies the lowest credit risk.
The
rating revision takes into consideration the company's
stable cash flows from the licensee area and reduced vulnerability
to competitive pressures given the energy deficit in the
Western region. Clarity on regulatory issues with the
Maharashtra Electricity Regulatory Commission's (MERC)
announcement of tariff principles that would be adopted
from this year; and sale of non-core assets, which has
offset the impact of lower operating profitability have
also been taken into account.
Back
to News Review index page
BoI
to ramp up overseas operations
Kochi: The Bank of India intends to upgrade its
office in China, and set up a new branch in that country
as well. The bank also plans to open new offices in Karachi
and Lahore in Pakistan.
However
as far as the Pakistan operations are concerned there
are a lot of formalities still to be complied with before
these branches become a reality, bank officials said.
The
bank will also be upgrading its Vietnam office, and will
open a new subsidiary in Tanzania and a new branch in
Belgium. The bank has substantial exposure in the diamond
and jewellery business for which the Belgium office will
become a major facilitator. Belgium and New York are the
two major hubs for the global diamond business and the
bank already has an office in New York, officials said.
Almost
20 per cent of Bank of India's business turnover comes
from its international business. The bank has 23 branches
and offices abroad, including major centres such as London,
New York, Paris, Tokyo, Singapore, Hong Kong, Nairobi,
Vietnam, Shenzhan and Jakarta. By extending its global
reach, the bank plans to expand its global business.
The
corporate plan for the current year envisages operating
profits to touch Rs2,000 crore, deposits Rs93,450 crore,
advances Rs69,650 crore and net NPAs of less than 1 per
cent.
Back
to News Review index page
Baja
Auto Finance to raise share capital
Mumbai: Bajaj
Auto Finance Ltd has informed BSE that its board of
directors has approved the increase in the authorised
share capital of the company to Rs50 crore from the existing
Rs20 crore.
The
decision to raise funds through various means would be
taken up in the next board meeting, the company said.
Back
to News Review index page
UK
patents ruling: Crisil reaffirms outstanding ratings on
Ranbaxy
Mumbai: CRISIL has reaffirmed its outstanding ratings
on the fixed deposit and commercial paper programmes of
Ranbaxy Laboratories Ltd. The reaffirmation follows the
ruling of the UK High Court of Justice in a case filed
by Ranbaxy against Pfizer, challenging two of latter's
patents on atorvastatin (marketed by Pfizer as Lipitor).
The
court has ruled that one of Pfizer's patents is invalid,
but that Ranbaxy's product infringes the other patent.
Ranbaxy has announced that it intends to appeal against
the second decision.
The
ratings continue to reflect Ranbaxy's leading position
as the largest Indian player in the global generics market
and one of the top ten globally. Ranbaxy's strong position
as the third-largest player in the Indian pharmaceutical
market also drives its rating.
According
to a Crisil report, Ranbaxy's strong market position derives
support from its sound research and development capabilities
across process re-engineering (generics), specialty drugs,
novel drug delivery systems and basic research areas.
However,
Ranbaxy's declining profitability because of increasing
pricing pressures in its mainstay US market, growing R&D
expenditure, and high litigation costs continues to be
a key rating sensitivity factor.
Back
to News Review index page
Banking
Results: UTI Bank
UTI
Bank net up 136 per cent to Rs.109 crore
Mumbai:
Mid-sized UTI
Bank has reported a 135.85 per cent jump in net profit
to Rs109.01 crore in the second quarter ended September
30, 2005 from up from Rs46.22 crore a year earlier.
The net profit in July-September 2005 has grown at a compounded
annual rate of 30 per cent over two years, suggesting
that the bank's profitability is close to its growth trajectory,
said P J Nayak, chairman and managing director, UTI Bank.
UTI Bank's board has also approved proposals to float
two wholly-owned subsidiaries. One of them would be a
sales and services subsidiary to deal with bank's products.
This subsidiary will also help the bank boost sales of
its credit cards, proposed for launch in the fourth quarter
of 2005-06. The second subsidiary will be a venture capital
fund for providing finance to infrastructure.
In the second quarter of 2005-06, UTI Bank's total income
increased by 94.23 per cent at Rs865.73 crore against
Rs445.72 crore a year earlier. Net interest income (NII)
stood at Rs255.45 crore in July-September 2005, reflecting
a healthy increase of 41 per cent from Rs180.72 crore
a year earlier.
Advances grew by 75 per cent at Rs18,404 crore as at end
September 2005 from Rs10,498 crore a year ago.
The
bank's capital adequacy ratio was 11.77 per cent against
10.67 per cent a year earlier. Its net non-performing
assets were 1.03 per cent as on September 30, 2005.
Back
to News Review index page